§ 27-18-33.2. Pharmacy benefit manager requirements with respect to multi-source generic pricing updates to pharmacies.
(a) Definitions. As used herein:
(1) “Maximum-allowable cost” or “MAC” means the maximum amount that a pharmacy benefits manager will reimburse toward the cost of a drug;
(2) “Nationally available” means that there is an adequate supply available from regional or national wholesalers and that the product is not obsolete or temporarily unavailable;
(3) “Pharmacy-benefit manager” or “PBM” means an entity doing business in this state that contracts to administer or manage prescription-drug benefits on behalf of any carrier that provides prescription-drug benefits to residents of this state.
(b) Upon each contract execution or renewal, a PBM shall, with respect to contracts between a PBM and a pharmacy or, alternatively, a PBM and a pharmacy’s contracting representative or agent, such as a pharmacy services administrative organization (PSAO):
(1) Include in such contracts a requirement to update pricing information on the MAC list at least every ten (10) calendar days;
(2) Maintain a procedure to eliminate products from the list of drugs subject to such pricing, or modify MAC rates when such drugs do not meet the standards and requirements of this section as set forth, in order to remain consistent with pricing changes in the marketplace.
(c) PBM requirements for inclusion of products on a list of drugs subject to MAC pricing. In order to place a particular prescription drug on a MAC list, the PBM must, at a minimum, ensure that:
(1) The product must be listed as “A,” “AB,” or “B” rated in the most recent version of the United States Food and Drug Administration’s approved drug products with therapeutic equivalence evaluations, also known as the orange book, or has an “NR” or “NA” rating or similar rating by a nationally recognized reference; and
(2) The product must be nationally available.
(d) Standards for pharmacy appeals. All contracts between a PBM, a contracted pharmacy or, alternatively, a PBM and a pharmacy’s contracting representative or agent, such as a pharmacy services administrative organization (PSAO), shall include a process to appeal, investigate, and resolve disputes regarding MAC pricing. The process shall include the following provisions:
(1) The right to appeal shall be limited to fifteen (15) days following the initial claim;
(2) The appeal shall be investigated and resolved within fifteen (15) days following receipt of the appeal;
(3) A process by which a network pharmacy may contact the PBM regarding the appeals process;
(4) If the appeal is denied, the PBM shall provide the reason for the denial and identify the national drug code of a drug product that is available in adequate supply;
(5) If an appeal is upheld, the PBM shall make an adjustment to the list effective no later than one day after the date of determination; and
(6) The department of health shall exercise oversight and enforcement of this section.
History of Section.P.L. 2016, ch. 166, § 1; P.L. 2016, ch. 168, § 1.
Structure Rhode Island General Laws
Chapter 27-18 - Accident and Sickness Insurance Policies
Section 27-18-1. - “Policy of accident and sickness insurance” construed.
Section 27-18-1.1. - Definitions.
Section 27-18-2. - Form of policy.
Section 27-18-2.1. - Uniform explanation of benefits and coverage.
Section 27-18-3. - Required provisions.
Section 27-18-3.1. - Alternative coverage by employer.
Section 27-18-3.2. - Rules and regulations.
Section 27-18-3.3. - Penalties.
Section 27-18-3.4. - Judicial review.
Section 27-18-3.5. - Non-applicability.
Section 27-18-4. - Optional provisions.
Section 27-18-5. - Inapplicable or inconsistent provisions.
Section 27-18-6. - Sequence of provisions.
Section 27-18-7. - Third party ownership.
Section 27-18-8. - Filing of accident and sickness insurance policy forms.
Section 27-18-8.1. - Waiting period — Effective date of filings.
Section 27-18-8.2. - Notice of disapproval.
Section 27-18-8.3. - Withdrawal of approval.
Section 27-18-8.4. - Rules as to filing.
Section 27-18-9. - Policies of foreign insurers.
Section 27-18-10. - Compliance by domestic insurer with laws of other states.
Section 27-18-11. - Application of provisions to policy issued to nonresident.
Section 27-18-12. - Less favorable provisions prohibited.
Section 27-18-13. - Effect of policies inconsistent with chapter.
Section 27-18-14. - Copies of applications.
Section 27-18-15. - Alteration of application.
Section 27-18-16. - False statements in application.
Section 27-18-17. - Acts not constituting waiver of insurer’s defenses.
Section 27-18-18. - Acceptance of premiums after effective period of policy.
Section 27-18-19. - Insurance exempt from chapter.
Section 27-18-20. - Penalties for violations.
Section 27-18-21. - Appeals from commissioner.
Section 27-18-22. - Effect on other law.
Section 27-18-23. - Severability.
Section 27-18-24. - Immunity of benefits from process.
Section 27-18-25. - Unfair discrimination prohibited.
Section 27-18-26. - Physical examinations by insurance company.
Section 27-18-27. - Adoptive children.
Section 27-18-28. - [Repealed.]
Section 27-18-29. - Changing coverage.
Section 27-18-30. - Health insurance contracts — Infertility.
Section 27-18-31. - Insurance coverage for services of licensed midwives.
Section 27-18-32. - Discontinuance of coverage — Chronic disabilities.
Section 27-18-33. - Drug coverage.
Section 27-18-33.1. - Insurance coverage for post-partum hospital stays.
Section 27-18-36.1. - Repealed.
Section 27-18-36.2. - Repealed.
Section 27-18-36.3. - Repealed.
Section 27-18-38. - Diabetes treatment.
Section 27-18-39. - Mastectomy treatment.
Section 27-18-40. - Insurance coverage for mastectomy hospital stays.
Section 27-18-41. - Mammograms and pap smears — Coverage mandated.
Section 27-18-42. - Mammograms — Quality assurance standards.
Section 27-18-43. - Pap smears — Quality assurance standards.
Section 27-18-44. - Primary and preventive obstetric and gynecological care.
Section 27-18-44.1. - Hysterectomy or myomectomy treatment.
Section 27-18-45. - Whistleblowers protection.
Section 27-18-46. - Penalties and remedies.
Section 27-18-47. - Additional relief and damages — Reinstatement.
Section 27-18-48. - Third party reimbursement for services of certain healthcare workers.
Section 27-18-48.1. - Third party reimbursement for services of registered nurse first assistants.
Section 27-18-49. - Human leukocyte antigen testing.
Section 27-18-50. - Drug coverage.
Section 27-18-50.1. - Medication synchronization.
Section 27-18-51. - Restricted annual rate payments prohibited.
Section 27-18-52. - Genetic testing.
Section 27-18-52.1. - Genetic information.
Section 27-18-53. - Magnetic resonance imaging — Quality assurance standards.
Section 27-18-54. - Health insurance rates.
Section 27-18-55. - Acupuncture services.
Section 27-18-56. - Prohibition against dentists being required to indemnify provider.
Section 27-18-57. - F.D.A. approved prescription contraceptive drugs and devices.
Section 27-18-59. - Eligibility for children’s benefits.
Section 27-18-60. - Hearing aids.
Section 27-18-61. - Prompt processing of claims.
Section 27-18-62. - Mandatory coverage for certain lyme disease treatments.
Section 27-18-63. - Dental insurance assignment of benefits.
Section 27-18-64. - Coverage for early intervention services.
Section 27-18-65. - Post-payment audits.
Section 27-18-66. - Tobacco cessation programs.
Section 27-18-67. - Reimbursement for orthotic and prosthetic services.
Section 27-18-68. - Mandatory coverage for scalp hair prosthesis.
Section 27-18-69. - Licensed ambulance service.
Section 27-18-70. - Enteral nutrition products.
Section 27-18-71. - Prohibition on preexisting condition exclusions.
Section 27-18-72. - Prohibition on rescission of coverage.
Section 27-18-73. - Prohibition on annual and lifetime limits.
Section 27-18-74. - Coverage for individuals participating in approved clinical trials.
Section 27-18-75. - Medical loss ratio reporting and rebates.
Section 27-18-76. - Emergency services.
Section 27-18-77. - Internal and external appeal of adverse benefit determinations.
Section 27-18-78. - Primary care provider designation requirement.
Section 27-18-79. - Discretionary clauses.
Section 27-18-80. - Orally administered anticancer medication — Cost-sharing requirement.
Section 27-18-81. - Consumer notification.
Section 27-18-82. - Opioid antagonists.
Section 27-18-83. - Healthcare provider credentialing.
Section 27-18-84. - Health insurance contracts — Full year coverage for contraception.
Section 27-18-85. - Prohibition on discrimination in organ transplants.
Section 27-18-86. - Health insurance contracts — Copayments exemption for COVID-19 vaccinations.
Section 27-18-87. - Perinatal doulas.
Section 27-18-88. - Gender rating. [Effective January 1, 2023.]